Hostname: page-component-6bf8c574d5-h6jzd Total loading time: 0.001 Render date: 2025-02-15T23:51:08.856Z Has data issue: false hasContentIssue false
  • English
  • Français

Drug induced otalgia due to mesalazine and sulphasalazine

Published online by Cambridge University Press:  29 June 2007

Michael Wareing  and
David Mitchell
Michael Wareing*
Affiliation:
Department of Otolaryngology, Kent and Canterbury Hospital, Canterbury, UK.
David Mitchell
Affiliation:
Department of Otolaryngology, Kent and Canterbury Hospital, Canterbury, UK.
*
Address for correspondence: Mr M. J. Wareing, Department of Otolaryngology, Kent and Canterbury Hospital, Ethelbert Road, Canterbury CT1 3NG.
Get access Rights & Permissions [Opens in a new window]

Abstract

A case of left otalgia in a patient suffering from longstanding ulcerative colitis is reported. The patient was treated for an exacerbation of his disease with courses of mesalazine and sulphasalazine during which time he developed otalgia. The otalgia disappeared with cessation of the drugs. It is concluded that in the absence of any other head and neck cause that the otalgia was a complication of the drug therapy.

Keywords

EaracheSalicylazosulphapyridine
Type
Clinical Records
Information
The Journal of Laryngology & Otology , Volume 110 , Issue 5 , May 1996 , pp. 466 - 467
Copyright
Copyright © JLO (1984) Limited 1996

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alstead, E. M., Wilson, A. G., Farthing, M. J. (1991) Lichen planus and mesalazine. Journal of Clinical Gastroenterology 13 (3): 335–337.CrossRefGoogle ScholarPubMed
Brimblecombe, R. (1990) Mesalazine: a global safety evaluation. Scandinavian Journal of Gastroenterology 25 (suppl 172): 66–68.CrossRefGoogle Scholar
Fardy, J. M., Lloyd, D. A., Reynolds, R. P. (1988) Adverse effects with oral 5-aminosalicylic acid. Journal of Clinical Gastroenterology 10 (6): 635–637.CrossRefGoogle Scholar
Hadjigogos, K. (1991) Unusual side effects of mesalazine. Italian Journal of Gastroenterology 23: 257.Google ScholarPubMed
Masson, E. A., Rhodes, J. M. (1992) Mesalazine associated nephrogenic diabetes insipidus presenting as weight loss. Gut 33 (4): 563–564.CrossRefGoogle ScholarPubMed
Pent, M. T., Ganapathy, S., Holdsworth, C. D., Channer, K. C. (1992) Mesalazine induced lupus like syndrome. British Medical Journal 305: 159.CrossRefGoogle ScholarPubMed
Pullar, T. (1992) Adverse effects of sulphasalazine. Adverse Drug Reaction and Toxicological Reviews 11 (2): 93–109.Google ScholarPubMed
Reinoso, M. A., Schroeder, K. W., Pisani, R. J. (1992) Lung disease associated with orally administered mesalamine for ulcerative colitis. Chest 101 (5): 1469–1471.CrossRefGoogle ScholarPubMed
Ruderman, W. B. (1990) Newer pharmacologic agents for the therapy of inflammatory bowel disease. Medical Clinics of North America 74 (1): 133–153.CrossRefGoogle ScholarPubMed